Warum steigt der Aktienkurs von INTUITIVE SURGICAL?
Bullen sagen
Physician training and adoption runway
Analyst expects a generational shift in physician training to expand the pool of surgeons comfortable with robotics, creating a multi-year adoption runway for additional procedures.
Regulatory clearance and clinical evidence
A confirmatory clinical study showing completed procedures without device-related serious adverse events, together with a non-commercial FDA clearance, supports continued clinical evidence development for a flexible gastrointestinal robotic system.
Gastrointestinal procedure growth
Analyst's TAM work and clinician feedback indicate meaningful upside from advanced endoscopic procedures as robotic systems can shorten procedure times and improve economics, encouraging wider use.
Competition from new platforms
Emerging competitors with smaller operating room footprints and flexible deployment models could pressure market share and accelerate adoption away from incumbents.
Bariatric demand headwinds
Widespread use of GLP-1 weight-loss drugs is reducing bariatric procedure volumes, which may constrain demand for bariatric-related robotic applications.
Procedure deferrals and U.S. growth risk
Patient-driven deferrals concentrated in non-urgent general surgeries and hospital prioritization of system upgrades over new installs could continue to weigh on U.S. procedure growth and revenue momentum.
